Biology of Flt3 Ligand, a Novel Regulator of Hematopoietic Stem and Progenitor Cells

作者: Hilary J. McKenna , Stewart D. Lyman

DOI: 10.1007/978-4-431-68320-9_11

关键词: HaematopoiesisStem cellInterleukin 3Stem cell factorCell biologyEndothelial stem cellT cellB cellBiologyProgenitor cell

摘要: Flt3 Ligand (F1t3L) is a protein that plays key role in the regulation of early events development multiple hematopoietic lineages. F1t3L stimulates primitive multipotent precursors, as well more committed or restricted myeloid precursors. has an effect on B cell T development, at least embryo. These effects Flt3L precursors are similar to those observed with Steel factor (SLF), and both these proteins synergize variety cytokines stimulate proliferation cells. However, there number differences between biological two factors, most notable being lack mast Mice lacking receptor have mild defect stem cells isolated from mice impaired ability reconstitute lethally irradiated recipients. Serum levels normally quite low healthy humans (< 100 pg/ml), but highly elevated individuals afflicted anemias component, such Fanconi acquired aplastic anemia, not single lineage anemias, Diamond­Blackfan. data suggest FIt3L may be physiological regulator vivo. find clinical utility treatment disorders, especially involving

参考文章(35)
H. G. Drexler, D. Birnbaum, Zhen-Bo Hu, Weili Ma, O. Rosnet, N. Dasilva, Expression of the FLT3 gene in human leukemia-lymphoma cell lines. Leukemia. ,vol. 8, pp. 885- 888 ,(1994)
HJ McKenna, P de Vries, K Brasel, SD Lyman, DE Williams, Effect of flt3 Ligand on the Ex Vivo Expansion of Human CD34+ Hematopoietic Progenitor Cells Blood. ,vol. 86, pp. 3413- 3420 ,(1995) , 10.1182/BLOOD.V86.9.3413.BLOODJOURNAL8693413
R Rottapel, P Dubreuil, L Forrester, A Bernstein, A D Reith, The murine W/c-kit and Steel loci and the control of hematopoiesis. Seminars in Hematology. ,vol. 28, pp. 138- 142 ,(1991)
O Rosnet, C Schiff, MJ Pebusque, S Marchetto, C Tonnelle, Y Toiron, F Birg, D Birnbaum, Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood. ,vol. 82, pp. 1110- 1119 ,(1993) , 10.1182/BLOOD.V82.4.1110.1110
Quentmeier H, Meierhoff G, Drexler Hg, Dehmel U, Birnbaum D, Rosnet O, Dirks W, Gruss Hj, Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia. ,vol. 9, pp. 1368- 1372 ,(1995)
Lyman Sd, Gruss Hj, Escobar S, Anderberg R, Brasel K, de Vries P, Expression of the flt3 receptor and its ligand on hematopoietic cells Leukemia. ,vol. 9, pp. 1212- 1218 ,(1995)
Lyman, Biology of flt3 ligand and receptor. International Journal of Hematology. ,vol. 62, pp. 63- 73 ,(1995) , 10.1016/0925-5710(95)00389-A
SD Lyman, L James, L Johnson, K Brasel, P de Vries, SS Escobar, H Downey, RR Splett, MP Beckmann, HJ McKenna, Cloning of the human homologue of the murine flt3 ligand : a growth factor for early hematopoietic progenitor cells Blood. ,vol. 83, pp. 2795- 2801 ,(1994) , 10.1182/BLOOD.V83.10.2795.2795
E. R. Stanley, P. Roth, The biology of CSF-1 and its receptor. Current Topics in Microbiology and Immunology. ,vol. 181, pp. 141- 167 ,(1992) , 10.1007/978-3-642-77377-8_5
SD Lyman, M Seaberg, R Hanna, J Zappone, K Brasel, JL Abkowitz, JT Prchal, JC Schultz, NT Shahidi, Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia Blood. ,vol. 86, pp. 4091- 4096 ,(1995) , 10.1182/BLOOD.V86.11.4091.BLOODJOURNAL86114091